Acorda Therapeutics gets grant for sustained release 4-aminopyridine tablets for neurological disorders

Discover Acorda Therapeutics' innovative patent for sustained release 4-aminopyridine tablets, designed for effective once-daily oral administration.

Aug 23, 2024 - 04:00
Discover Acorda Therapeutics' innovative patent for sustained release 4-aminopyridine tablets, designed for effective once-daily oral administration.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow